利德曼(300289.SZ)终止投资合作协议 拟转让武汉利德曼51%股权予李红波
格隆汇9月3日丨利德曼(300289.SZ)公布,公司经第三届董事会第十五次会议审议批准,公司与李红波共同投资设立了武汉利德曼医疗器械有限公司(“目标公司”或“武汉利德曼”),并持有目标公司51%的股权。
因合作情况发生变化,在双方友好协商的基础上,经公司第四届董事会第十五次会议审议批准,公司于2019年9月3日与李红波等签署《投资合作协议之终止协议》(“《终止协议》”),约定自2019年9月3日起终止原签订的《北京利德曼生化股份有限公司与李红波关于设立
<湖北利德曼医疗器械有限公司>
(暂定名)的投资合作协议》及《
<投资合作协议>
之补充协议》(合称为“《投资合作协议》”)。
投资合作协议>
湖北利德曼医疗器械有限公司>
《终止协议》的主要内容(甲方:北京利德曼生化股份有限公司;乙方:李红波;丙方:马煜南;丁方:武汉利德曼医疗器械有限公司):因终止合资,甲方同意将其持有的目标公司51%的股权转让给乙方,乙方亦同意受让上述股权。甲乙双方确认,本次交易的股权转让价格以甲方聘请的会计师事务所对目标公司2019年7月31日(“基准日”)的净资产审计结果(“审计结果”)为参考依据,经甲乙双方协商确定,乙方以人民币742万元的价格收购甲方持有的标的股权。协议生效后至2019年12月31日前,乙方应以人民币742万元的价格收购甲方持有的目标公司51%的股权。
公司完成对持有的武汉利德曼51%股权转让后,武汉利德曼将不再纳入公司合并报表范围。通过股权转让,公司可收回投资资金,用于补充流动资金或其他项目投资。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.